| Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis S Mocellin, S Pasquali, CR Rossi, D Nitti Journal of the National Cancer Institute 102 (7), 493-501, 2010 | 689 | 2010 |
| The dual role of IL-10 S Mocellin, MC Panelli, E Wang, D Nagorsen, FM Marincola Trends in immunology 24 (1), 36-43, 2003 | 633 | 2003 |
| Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy G Novara, V Ficarra, S Mocellin, TE Ahlering, PR Carroll, M Graefen, ... European urology 62 (3), 382-404, 2012 | 560 | 2012 |
| Interleukin-10 and the immune response against cancer: a counterpoint S Mocellin, FM Marincola, HA Young Journal of leukocyte biology 78 (5), 1043-1051, 2005 | 553 | 2005 |
| Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities S Mocellin, V Bronte, D Nitti Medicinal research reviews 27 (3), 317-352, 2007 | 531 | 2007 |
| Tumor necrosis factor, cancer and anticancer therapy S Mocellin, CR Rossi, P Pilati, D Nitti Cytokine & growth factor reviews 16 (1), 35-53, 2005 | 422 | 2005 |
| The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an … A Marchet, S Mocellin, A Ambrosi, P Morgagni, D Garcea, D Marrelli, ... Annals of surgery 245 (4), 543, 2007 | 415 | 2007 |
| Postoperative adjuvant chemotherapy in rectal cancer operated for cure. SH Petersen, H Harling, LT Kirkeby, P Wille‐Jørgensen, S Mocellin Cochrane database of systematic reviews, 2012 | 406 | 2012 |
| IL4Rα+ myeloid-derived suppressor cell expansion in cancer patients S Mandruzzato, S Solito, E Falisi, S Francescato, V Chiarion-Sileni, ... The Journal of immunology 182 (10), 6562-6568, 2009 | 387 | 2009 |
| Gastrointestinal stromal tumors: from a surgical to a molecular approach CR Rossi, S Mocellin, R Mencarelli, M Foletto, P Pilati, D Nitti, M Lise International Journal of Cancer 107 (2), 171-176, 2003 | 342 | 2003 |
| Bleomycin-based electrochemotherapy: clinical outcome from a single institution’s experience with 52 patients LG Campana, S Mocellin, M Basso, O Puccetti, GL De Salvo, ... Annals of Surgical Oncology 16, 191-199, 2009 | 312 | 2009 |
| Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness E Wang, LD Miller, GA Ohnmacht, S Mocellin, A Perez-Diez, D Petersen, ... Cancer research 62 (13), 3581-3586, 2002 | 311 | 2002 |
| The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle S Mocellin, F Marincola, CR Rossi, D Nitti, M Lise Cytokine & growth factor reviews 15 (1), 61-76, 2004 | 307 | 2004 |
| Circulating tumor cells: the ‘leukemic phase’of solid cancers S Mocellin, U Keilholz, CR Rossi, D Nitti Trends in molecular medicine 12 (3), 130-139, 2006 | 294 | 2006 |
| Cytokines and immune response in the tumor microenvironment S Mocellin, E Wang, FM Marincola Journal of immunotherapy 24 (5), 392-407, 2001 | 292 | 2001 |
| Systemic treatments for metastatic cutaneous melanoma S Pasquali, AV Hadjinicolaou, VC Sileni, CR Rossi, S Mocellin Cochrane Database of Systematic Reviews, 2018 | 264 | 2018 |
| The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis S Mocellin, D Hoon, A Ambrosi, D Nitti, CR Rossi Clinical cancer research 12 (15), 4605-4613, 2006 | 259 | 2006 |
| Quantitative real-time PCR: a powerful ally in cancer research S Mocellin, CR Rossi, P Pilati, D Nitti, FM Marincola Trends in molecular medicine 9 (5), 189-195, 2003 | 257 | 2003 |
| Interferon alpha for the adjuvant treatment of cutaneous melanoma S Mocellin, MB Lens, S Pasquali, P Pilati, VC Sileni Cochrane database of systematic reviews, 2013 | 247 | 2013 |
| Part I: Vaccines for solid tumours S Mocellin, S Mandruzzato, V Bronte, M Lise, D Nitti The Lancet Oncology 5 (11), 681-689, 2004 | 246 | 2004 |
